ESR1 and breast carcinoma: These findings also confirm our observations that FOXO3a inhibited the growth of estrogen-dependent breast cancer cells both in culture and in an orthotopic mouse model of breast cancer, suggesting that FOXO3a is involved in suppressing tumor growth or tumorigenesis and ER-mediated signaling in ER-positive breast tumors in vivo.